1928:HKEXSands China Ltd. Analysis
Data as of 2026-07-21 - not real-time
HK$13.46
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Sands China trades just above its 20‑day moving average but remains under the 50‑day and 200‑day averages, confirming a short‑term bearish bias despite a modestly bullish MACD histogram. The RSI sits near the midpoint, suggesting neither overbought nor oversold conditions, while the stock’s beta is well below one, indicating limited correlation with broader market moves. Volatility is elevated at roughly 31% over the past month, and the price is perched near a clear technical support zone, with resistance only a few cents away. On the fundamentals side, the company delivers a very high dividend yield of over 7%, a payout ratio under 60%, and a solid operating cash flow stream, but it carries an extreme debt‑to‑equity ratio exceeding 500%, which raises solvency concerns. The DCF model values the shares far below the current market price, yet analysts project a median target near HK$20.75, implying a sizeable upside potential. Forward earnings multiples are attractive relative to historical levels, and revenue growth remains healthy at double‑digit rates. Overall, the blend of attractive yield, upside from analyst expectations, and high leverage creates a nuanced risk‑reward profile that warrants careful positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering near technical support
- bearish trend despite bullish MACD signal
- high dividend yield offering immediate income
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- analyst consensus targets indicating ~50% upside
- forward PE discount to historical averages
- steady revenue growth and strong operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- excessive leverage and debt‑service obligations
- significant regulatory and geopolitical exposure in Macau
- sustainable dividend supported by cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth12.00%
Profit Margin12.04%
P/E Ratio15.5
ROE73.68%
ROA7.47%
Debt/Equity506.57
P/B Ratio9.9
Op. Cash FlowHK$2.1B
Free Cash FlowHK$849.6M
Technical Analysis
TrendBearish
RSI46.7
SupportHK$12.77
ResistanceHK$13.73
MA 20HK$13.24
MA 50HK$14.44
MA 200HK$17.76
MACDBullish
VolumeStable
Fear & Greed Index90.14
Valuation
Fair ValueHK$1.57
Target PriceHK$20.41
Upside/Downside51.64%
GradeFair
TypeBlend
Dividend Yield7.65%
Risk Assessment
Beta0.53
Volatility30.95%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.